Stockholm, Sweden

Peter Teodorovic

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Novartis Ag, Oncopeptides Innovation Ab, Other. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Teodorovic. Retrieved from https://idiyas.com/inventor/peter-teodorovic-ub9y9zsv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 3,977 
 
Novartis Ag
 patents
silverMedal1 out of 2 
 
Oncopeptides Innovation Ab
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Peter Teodorovic: Innovator in Meningitis A Vaccine Development

Introduction

Peter Teodorovic is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of vaccine development, particularly focusing on immunogens for meningitis-A vaccines. His innovative work has the potential to impact public health positively.

Latest Patents

Peter Teodorovic holds 1 patent for his invention titled "Immunogens for meningitidis-A vaccines." This patent describes an oligosaccharide that is useful for a Meningitidis A vaccine. The oligosaccharide contains a first mannose unit with a spacer in the alpha configuration at C-1, which is capable of conjugating to a protein. This unit is connected to a second mannose unit through a 1,6-linkage, which connects C-6 of the first unit to C-1 of the second unit. The 1,6-linkage comprises a phosphonate, and the patent also discloses related methods for making such compounds and their intermediates.

Career Highlights

Throughout his career, Peter has worked with prominent companies, including Novartis AG. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in vaccine development.

Collaborations

Peter has collaborated with esteemed colleagues such as Stefan Oscarson and Paolo Costantino. These partnerships have likely contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Peter Teodorovic is a distinguished inventor whose work in meningitis-A vaccine development showcases his commitment to improving public health. His innovative patent and collaborations highlight his significant contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…